Physician profile
Quy Vinh
NPI 1497783740
$2,875.49
in general payments reported to CMS, 2019-2025
9 companies · $93.77 in 2025
The $93.77 reported for 2025 was less than what a typical Adolescent Medicine (Family Medicine) provider received nationally (typical 2025 total: $135).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $255 · 2021: $393 · 2022: $480 · 2023: $443 · 2024: $225 · 2025: $93.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,143.53 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $491.36 | 2019-2024 | |
| Novo Nordisk INC | $58.43 | 2021-2024 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $57.72 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Teva Pharmaceuticals USA, INC. | $38.81 | 2019-2021 | |
| Lilly USA, LLC | $33.60 | 2021-2022 | |
| Abbott Laboratories | $23.75 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.90 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quy Vinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.